Status:
ENROLLING_BY_INVITATION
GLP_1 RA Ultrasound Study
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Glucagon Like Peptide-1 (GLP-1
Delayed Gastric Emptying
Eligibility:
All Genders
10-25 years
Brief Summary
The purpose of the study is to determine whether patients taking GLP-1 RAs have increased residual (left behind), gastric (stomach), contents due to delayed gastric emptying when following standard pr...
Eligibility Criteria
Inclusion
- Body Mass Index over 35
- Type 2 Diabetes
- Currently taking GLP01 RA agonist (for GLP 1 group)
- Not taking GLP-1 RA agonist (for control group)
Exclusion
- Diagnosis of gastroparesis
- patient refusal to participate
- Previous gastric bypass or any other gastric surgery
- Currently on peritoneal dialysis
- Abdominal pathology
- Gastro-intestinal obstruction
- Pregnancy
Key Trial Info
Start Date :
July 8 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06581120
Start Date
July 8 2024
End Date
July 1 2026
Last Update
November 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital
Cincinnati, Ohio, United States, 45299